Fear of cancer recurrence therapy (FORT): A randomized controlled trial.
Maheu C, Lebel S, Bernstein LJ, Courbasson C, Singh M, Ferguson SE, Harris C, Jolicoeur L, Baku L, Muraca L, Ramanakumar AV, Lamonde F, Lefebvre M, Tomei C, Mutsaers B, Secord S, Power J, Drummond N, Hébert M, Wani RJ.
Maheu C, et al. Among authors: bernstein lj.
Health Psychol. 2023 Mar;42(3):182-194. doi: 10.1037/hea0001253.
Health Psychol. 2023.
PMID: 36862474
Clinical Trial.
OBJECTIVE: Most fear of cancer recurrence (FCR) interventions have small effects, and few target FCR. This randomized controlled trial (RCT) with breast and gynecological cancer survivors evaluated the efficacy of a cognitive-existential fear of recurrence therapy ( …
OBJECTIVE: Most fear of cancer recurrence (FCR) interventions have small effects, and few target FCR. This randomized controlled tria …